Programs
Employer Branding Student Partner
Pharmacology & Drug Discovery Research Intern
Step 1: Apply for your favorite Internship
After you apply, you will receive an offer letter instantly. No queues, no uncertainty—just a quick start to your career journey.
Step 2: Submit Your Task(s)
You will be assigned weekly tasks to complete. Submit them on time to earn your certificate.
Step 3: Your task(s) will be evaluated
Your tasks will be evaluated by our team. You will receive feedback and suggestions for improvement.
Step 4: Receive your Certificate
Once you complete your tasks, you will receive a certificate of completion. This certificate will be a valuable addition to your resume.
About this Internship
A desk-based introduction to pharmacology and drug discovery: mechanisms of drug action, target identification, structure-activity relationships, free online tools for predicting drug properties, and the design of pre-clinical study programmes. No laboratory access is needed. All tasks are written documents based on published information and free web tools.
Tasks and Duties
Week 1: Drug Target and Mechanism Review
Summary
Write a referenced review of one drug target and its ligands.
Objective
Choose one well-characterised drug target such as the angiotensin-converting enzyme, the beta-adrenergic receptor, dipeptidyl peptidase-4, the sodium-glucose cotransporter 2 or cyclo-oxygenase, and write an introduction describing its biological function, its tissue distribution, its role in the disease it is linked to, and the history of how it was identified and validated as a drug target.
Describe the pharmacology of the target in depth, including the type of target such as enzyme, G-protein coupled receptor, ion channel or transporter, the concepts of affinity, efficacy, potency, agonism, antagonism, inverse agonism and allosteric modulation as they apply to this target, and the dose-response relationship with a diagram described in words.
Review at least six approved or investigational drugs acting on the target, presenting a table with the drug name, the year of approval, the chemical class, the mechanism of interaction with the target, the main indication, the key pharmacokinetic features and the major adverse effects, and draw or describe the chemical structures and identify the structural features common to the class.
Write a structure-activity relationship discussion of at least three hundred words explaining which parts of the molecules are essential for activity, how modifications changed potency, selectivity or duration, and what the next generation of drugs for this target is trying to achieve, with at least ten references in Vancouver style, then submit the complete review as a 5-6 page Word or PDF document.
Week 2: Drug Discovery Pipeline Analysis
Summary
Analyse the drug discovery process and a real pipeline.
Objective
Describe each stage of modern drug discovery and development in detail, including target identification and validation, hit identification by high-throughput screening or virtual screening, hit-to-lead and lead optimisation, pre-clinical development, the investigational new drug application, the three clinical phases, regulatory review and post-marketing studies, giving for each stage the typical duration, the approximate cost, the success rate and the key decision criteria.
Explain the main reasons why drug candidates fail at each stage using published analyses of attrition, covering lack of efficacy, safety and toxicity, poor pharmacokinetics, commercial reasons and strategic decisions, and describe at least three strategies the industry uses to reduce attrition such as biomarker-driven development, the rule of five and early toxicity screening.
Select one real pharmaceutical company with a publicly available research pipeline on its website, summarise its current pipeline in a table showing at least ten candidates with their therapeutic area, mechanism, phase and expected milestone, and analyse the company's apparent research strategy, its therapy area focus and the balance of risk in its portfolio.
Write a section of at least three hundred words on the drug discovery landscape in India, covering the contribution of Indian companies and institutes, the shift from generics to novel research, examples of new molecules discovered in India, government initiatives and the challenges faced, then submit the complete analysis as a 4-5 page Word or PDF document.
Week 3: In Silico Drug-likeness and ADMET Prediction
Summary
Predict and compare the properties of drug molecules using free web tools.
Objective
Explain the concepts of drug-likeness and the rules used to assess it including Lipinski's rule of five, Veber's rules and the quantitative estimate of drug-likeness, and explain the meaning and importance of each of the predicted pharmacokinetic and toxicity properties grouped under absorption, distribution, metabolism, excretion and toxicity, with reference to the reasons drugs fail in development.
Select six molecules acting on your chosen target from the earlier review, including at least one that was withdrawn or failed in development if possible, obtain their SMILES strings from PubChem, and run each molecule through at least two free web tools such as SwissADME, pkCSM or ProTox, recording the predicted values in detailed tables within your document with screenshots as evidence.
Compare the molecules systematically on lipophilicity, solubility, gastrointestinal absorption, blood-brain barrier penetration, cytochrome P450 interactions, P-glycoprotein substrate status, predicted hepatotoxicity and the number of rule violations, and discuss whether the predictions are consistent with the known clinical behaviour of the approved drugs and with the failure of any withdrawn compound.
Propose two structural modifications to the weakest compound in your set that might improve its predicted profile, run the modified structures through the same tools, present the before and after results, and write a critical reflection of at least two hundred and fifty words on the strengths and limitations of in silico prediction compared with experimental data, then submit the complete study as a 5-6 page Word or PDF document.
Week 4: Pre-clinical Development Plan
Summary
Design the pharmacology and toxicology programme for a lead compound.
Objective
Explain the purpose and regulatory basis of pre-clinical studies, describing the requirements under Schedule Y of the Drugs and Cosmetics Rules and the ICH M3 guideline for the non-clinical studies needed before the first human dose, including pharmacodynamics, safety pharmacology, pharmacokinetics, single and repeat dose toxicity, genotoxicity, local tolerance and the timing of reproductive and carcinogenicity studies.
Assume one of your modified compounds is selected as a lead for an oral tablet to be given daily for a chronic disease, and design the primary pharmacology programme including the in vitro binding and functional assays, the cell-based assays and at least two animal disease models with justification for the species, the endpoints and the dose ranges, presenting the studies in a table with their objectives and expected outputs.
Design the toxicology programme required to support a Phase I trial of up to four weeks, specifying for each study the species, the group sizes, the dose levels and how the top dose is chosen, the duration, the parameters monitored, the recovery groups and the Good Laboratory Practice requirement, and explain how the no-observed-adverse-effect level and the maximum recommended starting dose for humans are derived.
Add a section of at least three hundred words on animal ethics in India covering the role of the Committee for Control and Supervision of Experiments on Animals, the institutional animal ethics committee, the three R principles of replacement, reduction and refinement and the growing use of alternative methods, together with a timeline and approximate budget for your programme, then submit the complete plan as a 5-6 page Word or PDF document.
Launch Your Internship
Gain real-world skills, work on live projects and get an NSDC-affiliated certificate — absolutely free!